RE:RE:RE:Is it ok? Is $4M realistic?
- Launch of Ghryvelin™ in a number of key countries in the European Economic Area Following regional pricing approvals, Pharmanovia, our commercialization partner in the EEA, has launched Ghryvelin™ in the UK, Germany, Scandinavia and other countries in the EEA, and is expecting to launch Ghryvelin™ in additional countries in the EEA during the remainder of 2023 and into the first half of 2024
- Approval of Macrilen® in South Korea in September In South Korea, Macrilen® granules received MFDS approval in September